Our results also show that in primary BM-MSC–MM co-cultures established from bone marrow aspirates of myeloma patients, the BCMA expression of neoplastic plasma cells varies greatly between patients (~31–96%) according to the flow cytometric measurements. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.